Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
Latest Information Update: 22 Apr 2025
At a glance
- Drugs Naltrexone/bupropion (Primary) ; Orlistat (Primary) ; Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms STAY-LEAN
Most Recent Events
- 17 Apr 2025 Status changed from not yet recruiting to recruiting.
- 07 Mar 2025 New trial record